HWM
ALT icon

HighMark Wealth Management’s Altimmune ALT Stock Holding History

HighMark Wealth Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.16K Hold
2,000
– – ﹤0.01% 356
2025
Q4 		$7.22K Buy
+2,000
New +$8.72K ﹤0.01% 359

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HighMark Wealth Management's ALT Position: Q1 2026 in Review

HighMark Wealth Management held its Altimmune (ALT) position steady in Q1 2026 at 2,000 shares worth $6.16K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

HighMark Wealth Management first reported a position in ALT in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.22K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • HighMark Wealth Management held 2,000 shares of Altimmune worth $6.16K as of Q1 2026.
  • HighMark Wealth Management left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of HighMark Wealth Management's portfolio in Q1 2026, its #356 holding.
  • HighMark Wealth Management first reported a position in Altimmune in Q4 2025 and has held it in 2 quarters since.
  • HighMark Wealth Management's Altimmune position peaked at $7.22K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.